11 10, 2023 Use of whole genome sequencing to identify low-frequency mutations in SARS-COV-2 patients treated with remdesivir Neal Evan Caminsky2023-10-10T16:42:55-04:00October 11, 2023|Funded Research Results, Pillar 10|
27 09, 2023 Human-vision-inspired cluster identification for single-molecule localization microscopy Neal Evan Caminsky2024-12-16T09:50:07-05:00September 27, 2023|Funded Research Results, Pillar 4|
26 09, 2023 Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study Neal Evan Caminsky2023-09-26T10:49:59-04:00September 26, 2023|Funded Research Results, Pillar 4|
26 09, 2023 Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases Neal Evan Caminsky2023-09-26T10:41:44-04:00September 26, 2023|Funded Research Results, Pillar 4|
29 08, 2023 A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants Neal Evan Caminsky2023-08-29T11:51:33-04:00August 29, 2023|Funded Research Results, Pillar 10|
21 08, 2023 Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals Neal Evan Caminsky2023-08-23T14:40:13-04:00August 21, 2023|Funded Research Results, Pillar 2|
21 08, 2023 Clinical and serological predictors of Post COVID-19 Condition: Findings from a Canadian prospective cohort study Neal Evan Caminsky2023-08-23T14:41:36-04:00August 21, 2023|Funded Research Results, Pillar 9|
21 08, 2023 The metallodrug BOLD-100 is a potent inhibitor of SARS-CoV-2 replication and has broad-acting antiviral activity Neal Evan Caminsky2023-08-21T09:32:06-04:00August 21, 2023|Funded Research Results, Pillar 3|
8 08, 2023 Detection of prevalent SARS-CoV-2 variant lineages in wastewater and clinical sequences from cities in Québec, Canada Neal Evan Caminsky2024-04-24T14:50:28-04:00August 8, 2023|Funded Research Results, Pillar 5, Pillar 6|
3 08, 2023 Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection Neal Evan Caminsky2023-08-03T14:57:57-04:00August 3, 2023|Funded Research Results, Pillar 1|
